# 07 - Current-State Findings

## 1. Purpose

This document consolidates findings from the current-state assessment of the legacy connected infusion-pump environment at Heartland Integrated Health System (HIHS).

The findings bring together observations from the device inventory, interface inventory, current-state architecture, clinical workflow assessment, and cybersecurity assessment. They identify conditions, potential impacts, supporting evidence, and areas requiring further investigation.

The purpose of this document is to provide HIHS with a consolidated view of the current environment and support informed decision-making regarding subsequent assessment and modernization planning.

This document reflects a discovery-only assessment. It does not establish future-state requirements, select modernization solutions, or define implementation or remediation activities.

## 2. Assessment Components

The findings are based on the following assessment artifacts:

### 02 - Device Inventory

Documents the selected infusion-pump population, including device identification, location, lifecycle and support status, connectivity characteristics, and other relevant inventory attributes.

### 03 - Interface Inventory

Documents the current-state interfaces and integration dependencies associated with the selected infusion-pump environment, including connected systems, information flows, ownership, criticality, and operational dependencies.

### 04 - Current-State Architecture

Documents the major devices, systems, infrastructure, integration components, supporting services, and current-state information flows associated with the selected infusion-pump environment.

### 05 - Clinical Workflow Assessment

Documents current clinical workflow dependencies, information needs, connectivity relationships, lifecycle considerations, operational dependencies, and areas requiring further investigation.

### 06 - Cybersecurity Assessment

Documents cybersecurity considerations, including device lifecycle and support, connectivity and exposure, vulnerability and risk considerations, security dependencies, clinical and operational impact, and areas requiring further investigation.

## 3. Consolidated Current-State Findings

The following findings summarize the conditions and potential impacts identified during the current-state assessment. Findings requiring additional evidence or validation are identified accordingly.

| ID   | Finding                                                                                                                                                                  | Potential Impact                                                                                                                                                                       | Evidence                | Status                   |
| ---- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------------- | ------------------------ |
| F-01 | Vendor-dependent device integration may increase integration complexity and interface dependencies.                                                                      | Potential for increased maintenance effort, more complex testing or upgrade activities, and vendor-specific troubleshooting dependencies.                                              | C-03 / A-01–A-03        | Needs further assessment |
| F-02 | The current-state baseline contains information and validation gaps requiring additional discovery.                                                                      | Potential difficulty confirming interface ownership, data flows, monitoring coverage, security dependencies, vendor dependencies, facility-specific differences, and workflow impacts. | C-03 / A-01–A-03 / W-01 | Needs further assessment |
| F-03 | The infusion-pump environment includes devices with varying lifecycle and vendor-support conditions that may affect integration, security, and operational dependencies. | Potential for differing support, maintenance, upgrade, security-update, and integration considerations across the device population.                                                   | D-01 / W-01 / C-03      | Needs further assessment |
| F-04 | The connected infusion-pump environment has clinical workflow and information-flow dependencies that require continued validation.                                       | Unconfirmed dependencies or variations in information exchange may affect workflow continuity, operational coordination, and the assessment of clinical impact.                        | W-01 / C-03 / A-01–A-03 | Needs further assessment |
| F-05 | Monitoring and visibility dependencies exist across the device, network, and interface environment.                                                                      | Incomplete information about monitoring coverage, alerting, ownership, or operational visibility may limit the ability to assess connectivity and interface dependencies.              | A-01–A-03 / C-03        | Needs further assessment |
| F-06 | Cybersecurity considerations are closely connected to device lifecycle, connectivity, access, and clinical operations.                                                   | Unresolved security-support or visibility questions may affect the assessment of device exposure, operational dependencies, and clinical continuity.                                   | D-01 / C-03 / W-01      | Needs further assessment |
| F-07 | Facility-specific differences may affect the consistency of the current-state baseline.                                                                                  | Differences in device populations, connectivity, integration dependencies, or workflows may complicate consolidated assessment and comparison across facilities.                       | D-01 / C-03 / W-01      | Needs further assessment |

## 4. Finding Details

### F-01: Vendor-Dependent Device Integration

The current-state assessment identifies vendor-dependent device integration as a potential source of integration complexity and operational dependency.

Different device models, integration components, and vendor support arrangements may introduce differences in maintenance, troubleshooting, testing, and upgrade considerations.

Further investigation is needed to confirm the extent of these dependencies and their impact on the selected infusion-pump environment.

### F-02: Current-State Information and Validation Gaps

The assessment identifies areas where additional information or validation may be required to establish a complete current-state baseline.

These areas include interface ownership, information flows, monitoring coverage, security dependencies, vendor support, facility-specific differences, and clinical workflow impacts.

The identified gaps should be considered when interpreting the current-state findings and determining whether additional discovery is necessary.

### F-03: Device Lifecycle and Vendor-Support Variability

The selected infusion-pump environment includes devices with varying lifecycle and vendor-support conditions.

These differences may affect the availability of security updates, maintenance options, vendor support, integration dependencies, and operational considerations.

Additional validation of device lifecycle and support information is necessary to understand the extent of these differences and their potential implications.

### F-04: Clinical Workflow and Information-Flow Dependencies

The connected infusion-pump environment includes relationships between devices, clinical systems, information flows, and clinical workflows.

The assessment identifies these relationships as important considerations when evaluating the current environment. Additional validation may be required to confirm how connectivity, information exchange, and system dependencies affect clinical workflows across the selected facilities.

Potential impacts should be evaluated in the context of clinical workflow requirements and operational continuity.

### F-05: Monitoring and Visibility Dependencies

The current-state architecture identifies network monitoring and interface monitoring as supporting components of the infusion-pump environment.

The assessment identifies monitoring coverage, visibility, ownership, and operational dependencies as areas requiring consideration. Additional discovery may be needed to confirm the extent of monitoring available across devices, network connections, and integration components.

Until these details are validated, the completeness of current-state monitoring visibility remains an open assessment item.

### F-06: Cybersecurity and Operational Dependencies

Cybersecurity considerations are interconnected with device lifecycle, vendor support, network connectivity, access controls, monitoring, and clinical operations.

The assessment identifies these relationships as relevant to understanding potential cybersecurity exposure and operational impact. Further investigation may be necessary to confirm available security evidence, existing controls, and unresolved dependencies.

Cybersecurity concerns should be evaluated alongside clinical criticality and operational continuity rather than in isolation.

### F-07: Facility-Specific Differences

The selected infusion-pump environment spans multiple facilities and includes a range of device models and connectivity characteristics.

Facility-specific differences may affect device distribution, network connectivity, integration dependencies, monitoring, and clinical workflows.

Additional validation may be required to determine whether the current-state environment is consistent across facilities or whether differences need to be considered in subsequent analysis.

## 5. Cross-Cutting Assessment Observations

The consolidated findings identify several related areas that influence the understanding of the current-state environment.

* **Technical dependencies:** Device connectivity, integration components, network infrastructure, and connected systems contribute to the complexity of the environment.
* **Clinical and operational dependencies:** Device availability, information exchange, and workflow requirements must be considered together when evaluating potential impacts.
* **Lifecycle and support considerations:** Device age, vendor support, and security-update availability may affect maintenance, integration, and cybersecurity considerations.
* **Monitoring and visibility:** Understanding the availability and coverage of monitoring is important to assessing connectivity and operational dependencies.
* **Evidence and validation:** Additional discovery may be required to confirm assumptions, resolve information gaps, and establish a sufficiently complete current-state baseline.

These observations provide context for interpreting the individual findings and identifying areas that may require further investigation.

## 6. Risk and Gap Prioritization

The findings should be reviewed and prioritized based on the available evidence and the potential implications for the HIHS environment.

Relevant considerations include:

* Device clinical criticality
* Device lifecycle and vendor-support status
* Network connectivity and potential exposure
* Integration and information-flow dependencies
* Availability of security updates
* Monitoring and operational visibility
* Potential impact on clinical workflows
* Potential impact on operational continuity
* Completeness and reliability of supporting evidence

Prioritization should account for both the potential impact of an issue and the confidence in the available information. Findings that require additional validation should remain clearly distinguished from confirmed conditions.

## 7. Areas Requiring Further Investigation

The following areas may require additional discovery or validation before HIHS makes subsequent decisions:

* Confirmation of device inventory and lifecycle information
* Validation of vendor support and security-update availability
* Confirmation of interface ownership and information flows
* Validation of connectivity and integration dependencies
* Review of monitoring coverage and operational visibility
* Confirmation of access-control and cybersecurity dependencies
* Further assessment of clinical workflow and information-flow impacts
* Identification of relevant facility-specific differences
* Resolution of outstanding evidence gaps and assumptions

These activities are intended to clarify the current-state environment. They do not constitute an implementation or remediation plan.

## 8. Assessment Outcome

The Current-State Findings document consolidates the technical, clinical, operational, integration, and cybersecurity observations identified during the assessment of the legacy connected infusion-pump environment.

The findings provide HIHS with a structured view of:

* Potential integration complexity and vendor dependencies
* Current-state information and validation gaps
* Device lifecycle and vendor-support considerations
* Clinical workflow and information-flow dependencies
* Monitoring and visibility dependencies
* Cybersecurity and operational considerations
* Facility-specific differences requiring validation
* Areas requiring additional investigation and prioritization

The assessment establishes a foundation for understanding the existing environment and supporting subsequent decision-making.

The findings are intended to inform future analysis and planning. They do not prescribe specific modernization solutions, security controls, procurement decisions, or implementation activities.

## 9. Scope and Limitations

This document reflects a fictional, discovery-only assessment of the selected legacy connected infusion-pump environment at HIHS.

The findings are based on the supporting assessment artifacts and the information represented within them. Items identified as requiring further assessment should not be interpreted as confirmed deficiencies without additional supporting evidence.

The assessment does not include production testing, implementation, deployment, remediation, procurement, or validation of a future-state architecture.

The findings should be interpreted within these limitations and used as a basis for subsequent investigation and decision-making.
